Study title:
van-den-Berg-H, Furstner-F, van-den-Bos-C, Behrendt-H.
Department of Pediatric Oncology, Emma Children Hospital AMC,
University of Amsterdam, Amsterdam; The Netherlands.
h.vandenberg@amc.uva.nl.
Decreasing the number of MOPP courses reduces gonadal damage in survivors of childhood Hodgkin disease.
Pediatric blood & cancer, {Pediatr-Blood-Cancer}, Mar 2004, vol. 42, no. 3, p. 210-5, ISSN: 1545-5009.van-den-Berg-H, Furstner-F, van-den-Bos-C, Behrendt-H.
Department of Pediatric Oncology, Emma Children Hospital AMC,
University of Amsterdam, Amsterdam; The Netherlands.
h.vandenberg@amc.uva.nl.
Decreasing the number of MOPP courses reduces gonadal damage in survivors of childhood Hodgkin disease.
Pediatric blood & cancer, {Pediatr-Blood-Cancer}, Mar 2004,...
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Neoplasms [C04]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: PROCARBAZINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|